Bringing Science to Supplements
Investor Presentation
Brisbane, Feb 19, 2019 AEST (ABN Newswire) - Anatara Lifesciences (
ASX:ANR) is pleased to release a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, will be presenting at the Proactive Investors Australia CEO Sessions and the Wholesale Investor's Emergence 2019 conferences this month.
Details for Mr Lydeamore's presentations are as follows:
- Proactive Investors Australia - CEO Sessions
o Tuesday 19th February 2019 - arrive from 11:15am
o CQ Functions, 113 Queen Street, Melbourne
- Wholesale Investor's - Emergence 2019
o Thursday 28th February 2019 - 9am until 6pm
o InterContinental Sydney, L2 117 Macquarie Street, Sydney
The Anatara team plans a further market update and extensive investor roadshow in March.
To view the presentation, please visit:
http://abnnewswire.net/lnk/FS907GSW
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
| ||
|
